SCHEMBL29327924

SCHEMBL29327924

CCc1ccc(-c2nc3cc(NC(=O)c4cc(C#N)ccc4S(=O)(=O)C(F)(F)F)ccc3s2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.49
▸ HDAC6 Q9UBN7 2/20 0.46
▸ TP53 P04637 3/20 0.46
▸ THRB P10828 2/20 0.46
▸ MAPT P10636 2/20 0.45
▸ APP P05067 1/20 0.41
▸ SENP7 Q9BQF6 2/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ TRPV1 Q8NER1 3/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29327928 0.94 APP (0.48) PPARGHDAC6TP53THRBMAPT
SCHEMBL29327883 0.92 PPARG (0.52) PPARGHDAC6TP53THRBMAPT
SCHEMBL29327889 0.85 MAPT (0.56) PPARGHDAC6TP53THRBMAPT
SCHEMBL29327683 0.83 PPARG (0.72) PPARGTP53MAPTPPARASMN1; SMN2
SCHEMBL29327718 0.83 PPARG (0.53) PPARGTP53THRBNPC1ALDH1A1
SCHEMBL29327911 0.82 PPARG (0.46) PPARGTP53THRBNPC1ALDH1A1
SCHEMBL29327900 0.82 PPARG (0.46) PPARGTP53THRBNPC1ALDH1A1
SCHEMBL29327997 0.82 HDAC6 (0.47) PPARGHDAC6TP53THRBMAPT
SCHEMBL29327715 0.82 PPARG (0.47) PPARGHDAC6TP53THRBMAPT
SCHEMBL29327713 0.82 PPARG (0.63) PPARGTP53THRBMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239760-A1 PPARG INVERSE AGONISTS AND USES THEREOF FLARE THERAPEUTICS INC. 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239760-A1 PPARG INVERSE AGONISTS AND USES THEREOF PPARG, PPARA, PPARD PPARG 1/4885HDAC6 1654/4885TP53 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback